9 completed, 1 unknown. 4 Phase 2, 2 Not applicable, 2 Phase 4, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 4 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow pandemrix: new trials by email Literature Review of pandemrix trials Research Report on pandemrix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age Influenza A (H5N1) Virus monovalent vaccine (GSK1557484A). - Influenza | Phase 2 | Completed | GlaxoSmithKline | 185 | 2016-07-07 | 2019-06-27 |
| Assessment of Safety and Immunogenicity of Intradermal Unadjuvanted Portion of Pandemrix® Via a Microneedle Device With Intramuscular Adjuvanted Pandemrix® as Reference Pandemrix® (H1N1 pandemic influenza) - Healthy | Not applicable | Unknown | Hadassah Medical Organization | 200 | 2010-01-01 | 2009-12-25 |
| Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients Adjuvanted influenza A(H1N1) vaccines - HIV Infection, Rheumatic Disease | Phase 4 | Completed | University Hospital, Geneva | 1141 | 2009-11-01 | 2010-03-01 |
| Studies of Pandemic Influenza (H1N1) 2009 Vaccine in Bergen Adjuvanted influenza H1N1split virion vaccine - Healthy | Not applicable | Completed | University of Bergen | 255 | 2009-10-01 | 2019-11-18 |
| Influenza A/H1N1/2009-adjuvanted Vaccine in Renal Disease Patients Influenza A/H1N1 2009-AS03 adjuvanted (Pandemrix) - Decreased Immunologic Activity [PE], Influenza | Phase 4 | Completed | Erasme University Hospital | 185 | 2009-10-01 | 2011-02-17 |
| Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac) adjuvanted A(H1N1)v influenza vaccine, non-adjuvanted A(H1N1)v influenza vaccine - HIV Infections | Phase 2 | Completed | French National Agency for Research on AIDS and Viral Hepatitis | 306 | 2009-10-01 | 2026-04-07 |
| Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly Pandemrix (Influenza vaccine GSK2340272A), Fluarix™, Placebo - Influenza | Phase 2 | Completed | GlaxoSmithKline | 168 | 2009-09-12 | 2018-08-20 |
| Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1) Pandemrix (GSK investigational influenza GSK2340272A vaccine), Fluarix™, Placebo - Influenza | Phase 3 | Completed | GlaxoSmithKline | 145 | 2009-09-08 | 2018-08-17 |
| Swine Flu (Novel Influenza A H1N1) Vaccine Study Baxter Novel Influenza A H1N1 Whole Virus Vaccine, GlaxoSmithKline Novel Influenza A H1N1 Split Virion Vaccine - Influenza | Phase 2 | Completed | University of Oxford | 1000 | 2009-09-01 | 2013-05-09 |
| Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults Pumarix™, Pandemrix ™ - Influenza | Phase 1 | Completed | GlaxoSmithKline | 780 | 2007-07-28 | 2018-08-17 |
Influenza, Human (6) · HIV Infections (2) · Neoplasms (1) · Rejection, Psychology (1) · Rheumatic Diseases (1)
GlaxoSmithKline (4) · Erasme University Hospital (1) · French National Agency for Research on AIDS and Viral Hepatitis (1) · Hadassah Medical Organization (1) · University Hospital, Geneva (1) · University of Bergen (1) · University of Oxford (1)
Belgium (1) · Canada (1) · France (1) · Germany (1) · Israel (1) · Norway (1) · Sweden (1) · Switzerland (1) · Taiwan (1) · Thailand (1) · United Kingdom (1) · United States (1)
Adam Finn, PhD, FRCPCH (1) · Andrew Collinson, MRCPCH, MD (1) · Andrew Pollard, MRCP, PhD (1) · Daniel Abramowicz, PhD (1) · Haakon Sjursen, MD PhD (1) · Liz Miller, FRCPath, DSc (1) · Matthew Snape, FRCPCH, MD (1) · Odile Launay, MD (1) · Paul Heath, FRCPCH (1) · Per Espen Akselsen, MD (1) · Saul Faust, MRCPCH, PhD (1)
PMID 22885014, PMID 20423222, PMID 21034828, PMID 21384334, PMID 21419775, PMID 21422117, PMID 21438900, PMID 22228003, PMID 22634440, PMID 22848378, PMID 22969149, PMID 26009966, PMID 26057137, PMID 27789145, PMID 28007925, PMID 29893797, PMID 30131880, PMID 34285165, PMID 34938285
2009 (2), 2015 (1)